Patents for C12P 21 - Preparation of peptides or proteins (112,499)
10/2009
10/13/2009US7601805 Photoprotein with improved bioluminescence
10/13/2009US7601803 mutagenized bovine gamma-II-crystallin polypeptide with binding to the Hormone Estradiol; antibodies, enzymes
10/13/2009US7601687 Drug screening for non-insulin dependent diabetes mellitus, beta cell dysfunction and peripheral insulin resistance
10/13/2009US7601535 For in vitro cell culture which contain substantially saturated amounts of selected amino acids; improved exogenous gene expression; also extends cell longevity
10/13/2009US7601518 Secretion of neublastin
10/13/2009US7601517 Split protein self complementing fragments, systems, and methods of use thereof
10/13/2009US7601516 Follicle stimulating hormone-immunoglobulin fusion fo use in treatment of reproductive disorders
10/13/2009US7601515 Process of high purity albumin production
10/13/2009US7601514 Encodes a polypeptide which inhibits the proliferation of T-lymphocytes; use in diagnosis and treatment of immune disorders; PRO polypeptides; autoimmune disorders
10/13/2009US7601513 Recombinant methods for expressing a functional umami (T1R1/T1R3) taste receptor
10/13/2009US7601510 Development and use of fluorescent probes of unbound analytes
10/13/2009US7601508 Ecdysone receptor polypeptide from the homopteran whitefly (Bamecia argentifoli, BaEcR) use screening for monoclonal antibodies; biological insecticides
10/13/2009US7601352 Monoclonal antibodies and antigen binding fragments thereof capable of binding TrkA and inhibiting the functional activation of TrkA
10/13/2009US7601350 Antibodies that bind M. tuberculosis polypeptides
10/13/2009US7601349 GIPs, a family of polypeptides with transcription factor activity that interact with Goodpasture antigen binding protein
10/13/2009CA2222650C Tnf-.alpha. converting enzyme
10/13/2009CA2103583C Recombinant transferrins, transferrin half-molecules and mutants thereof
10/08/2009WO2009121483A1 Highly bridged peptides from actinomadura namibiensis
10/08/2009WO2005009350A3 Fugetactic proteins, compositions and methods of use
10/08/2009US20090255014 method for manipulation of cells and the resultant cells, wherein at least one gene from a psychrophilic micro organism coding for at least one chaperone or chaperonin is expressed; producing a protein by heterologous expression in a host cell
10/08/2009US20090255004 G-Protein Coupled Receptor and Uses Therefor
10/08/2009US20090255002 Transgenic Non-Human Animals For Producing Chimeric Antibodies
10/08/2009US20090253897 Structural protein of adeno-associated virus with modified antigenicity, its production and its use
10/08/2009US20090253779 Expression of Rbap48 in Memory and Aging and Methods Related Thereto
10/08/2009US20090253770 Target gene mimitin of myc
10/08/2009US20090253626 50 Human Secreted Proteins
10/08/2009US20090253619 Novel peptide involved in energy homeostasis
10/08/2009US20090253179 Permitting the increased production of recombinant proteins; culturing; introducing into the cells agents that inhibit senescence or that promote cell survival
10/08/2009US20090253178 Recombinant cell clones having increased stability and methods of making and using the same
10/08/2009US20090253177 lyases enzymes obtained from transformed plant tissue expressing polynucleotide that encodes the polypeptide; improved ethanol biosynthesis, stalk and nodal strength
10/08/2009US20090253176 Cell lines and methods for producing proteins
10/08/2009US20090253175 Use to faciliate drug delivery of other drugs, or treat glycosaminoglycan associated pathologies, such as scarring, spinal cord injury, glaucoma, and cosmetic treatments
10/08/2009US20090253174 Expression of Heterologous Sequences
10/08/2009US20090253173 Filamentous fungi with inactivated protease genes for altered protein production
10/08/2009US20090253172 Growth factor homolog zvegf4
10/08/2009US20090253171 Methods For Producing Secreted Polypeptides Having Biological Activity
10/08/2009US20090253170 Nucleotide sequences for regulating gene expression in plant trichomes and constructs and methods utilizing same
10/08/2009US20090253169 Use of genetically modified organisms to generate biomass degrading enzymes
10/08/2009US20090253168 improving the membrane permeability of a substrate, hydantoin-transporter activity; obtained by introducing and expressing the novel gene called mhp
10/08/2009US20090253167 Methanol-responsive promoter, fusion gene comprising promoter and foreign gene connected so that foreign gene can be expressed, vector, transformant, and method of producing protein
10/08/2009US20090253166 Conjugation of Peptides
10/08/2009US20090253165 Method for preparing microcapsules by coacervation
10/08/2009US20090253125 Denaturat stable and/or protease resistant, chaperone-like oligomeric proteins, polynucleotides encoding same, their uses and methods of increasing a specific activity thereof
10/08/2009US20090252749 Compositions and Methods for Producing a Composition
10/08/2009US20090252748 Sp35 Antibodies and Uses Thereof
10/08/2009US20090252743 Antibody for use in the treatment of crohn's and inflammatory diseases such as ankylosing spondylitis; human tumor necrosis factor alpha (TNF) inhibitors
10/08/2009US20090252729 Single-chain Fc (scFc) regions, binding polypeptides comprising same, and methods related thereto
10/08/2009US20090252726 Antibodies for inhibiting blood coagulation and methods of use thereof
10/08/2009US20090252722 Botulinum Neurotoxin a Protein Receptor and Uses Thereof
10/08/2009US20090252705 IL-6/IL-6R Fusion Protein
10/08/2009US20090252683 Composition Comprising Cross-Species-Sepecific Antibodies and uses Thereof
10/08/2009US20090252681 Nanobodies and Polypeptides Against EGFR and IGF-IR
10/08/2009DE19932688B4 Design von Beta-Faltblatt-Proteinen des gamma-II-kristallins antikörperähnlichen Design of beta-sheet proteins of the gamma-II-crystallin antibody-like
10/08/2009CA2720368A1 Her2/neu-specific antibodies and methods of using same
10/08/2009CA2720173A1 Highly bridged peptides from actinomadura namibiensis
10/07/2009EP2107128A2 Novel polynucleotides
10/07/2009EP2107115A1 Genetically recombinant antibody composition capable of binding specifically to ganglioside gm2
10/07/2009EP2107111A1 Heat stable mutants of starch biosynthesis enzymes
10/07/2009EP2107109A1 Recombinant vascular endothelial cell growth factor D (VEGF-D)
10/07/2009EP2107070A1 Rheumatoid arthritis remedy containing IL-6 antagonist as active ingredient
10/07/2009EP2106800A1 Blockade of T lymphocyte down-regulation associated with CTLA-4 signaling
10/07/2009EP2106447A1 Method for methanol independent induction from methanol inducible promoters in pichia
10/07/2009EP2106446A1 Stabilization of cyclic peptide structures
10/07/2009EP2106442A1 Cancerous disease modifying antibodies
10/07/2009EP2106441A1 Cancerous disease modifying antibodies
10/07/2009EP2106440A2 Non-simian cells for growth of porcine reproductive and respiratory syndrome (prrs) virus
10/07/2009EP1505075B1 Antibody to human insulin-like growth factor
10/07/2009EP1477562B1 Transcriptional factor, transcriptional factor gene, recombinant vector containing transcriptional factor gene, koji-mold transformed by the vector and method of using koji-mold
10/07/2009EP1191099B1 Novel polypeptide and dna thereof
10/07/2009EP1053329B1 RECOMBINANT LIPIDATED PsaA PROTEIN, METHODS OF PREPARATION AND USE
10/07/2009EP0907735B2 Modulators of tissue regeneration
10/07/2009EP0907730B1 Haemopoietin receptor and genetic sequences encoding same
10/07/2009CN101553255A Smallpox monoclonal antibody
10/07/2009CN101550436A Method for enhancing output of antibacterial substance A21978C
10/07/2009CN101550397A An animal and plant reagent peptone and method of producing the same
10/07/2009CN101550186A Sheep recombination prion protein and monoclonal antibody thereof and application
10/07/2009CN101550179A Sesbania peptone and production method thereof
10/07/2009CN101550178A Blood polypeptide and preparation method and application thereof
10/07/2009CN101549148A Application of polypeptide in preparing the medicine promoting the transformation from endocardium cell to interstitial cell
10/07/2009CN100547078C Methods for producing biological substances in enzyme-deficient mutants of aspergillus niger
10/07/2009CN100547003C Antibodies to human IL-1 beta
10/07/2009CN100546652C Deimmunized monoclonal antibodies for protection against and treating HIV infection
10/06/2009USRE40930 Porcine adenovirus type 3 genome
10/06/2009US7599799 Methods for using co-regulated genesets to enhance detection and classification of gene expression patterns
10/06/2009US7598355 Characterization of GRP94-ligand interactions and purification, screening, and therapeutic methods relating thereto
10/06/2009US7598353 Cancer; interferes with the interaction between CD200 and its receptor to block immune suppression thereby promoting eradication of the cancer cells; directly kills the cancer cells either by complement-mediated or antibody-dependent cellular cytotoxicity or by targeting cells using a fusion molecule
10/06/2009US7598352 Method of identifying polypeptide monobodies which bind to target proteins and use thereof
10/06/2009US7598351 Monoclonal antibody that specifically binds to a C-terminal partial peptide of the 19P2 ligand or a derivative and a hybridoma cell line that produces it, used for diagnosing hyperprolactinemia
10/06/2009US7598348 Adiponectin receptor variant, AdipoR2v2
10/06/2009US7598340 Monoclonal antibody to a human MDR1 multidrug resistance gene product, and uses
10/06/2009US7598232 Amino-substituted (E)-2,6-dialkoxystyryl 4-substituted-benzylsulfones for treating proliferative disorders
10/06/2009US7598080 Diagnostic assay for source of inflammation
10/06/2009US7598066 Gene encoding vitamin b6 phosphate phosphatase and use thereof
10/06/2009US7598063 Process for producing ethanol by using recombinant coryneform bacterium
10/06/2009US7598062 Process for the production of L-amino acids using strains of the family enterobacteriaceae that contain an attenuated fruR gene
10/06/2009US7598058 Nucleic acids encoding IL13 mutants
10/06/2009US7598056 Factor VII or VIIA-like molecules
10/06/2009US7598055 N-acetylglucosaminyltransferase III expression in lower eukaryotes
10/06/2009US7598052 Expression profile of thyroid cancer
10/06/2009US7598045 Detection of the PC-LECTIN protein which correlates to the presence of an androgen-dependent prostate cancer cell; drug target and diagnostic marker for prostate cancer